COVID-19 and Fertility: IHR Doctors Publish an important Systematic Review
IHR doctors, Drs Tur-Kaspa and Cohen, and their interns have published a timely and important review in the prestigious peer-reviewed journal Fertility & Sterility Reviews: “COVID-19 may affect male fertility but is not sexually transmitted: a systematic review”.
The aim of this paper was to review all of the global clinical data regarding COVID-19 effects on reproductive organs and cells, in order to investigate if COVID-19 affects male and/or female fertility and if it should be classified as a sexually transmitted disease (STD).
From a public health perspective, this distinction is very important with the spread of the virus. In addition, it is important for the clinical work of IVF labs and FDA guidelines outlining sperm and egg donations in the United States.
The conclusion of Dr. Tur-Kaspa and Dr. Cohen’s review was that COVID-19 is not an STD, since there has been no clinical evidence that the virus is present in sperm, eggs, or vaginal fluids, nor is it transmitted through intercourse.
However, there is evidence suggesting that COVID-19 may affect male fertility, and it should be further investigated. This happens primarily because of the negative effect that having a fever has on sperm, and because a viral infection may cause an inflammation reaction in the testes. It is not yet clear if COVID-19’s deleterious effect on sperm count and motility, as well as testosterone levels, is permanent or not.
So far there have been no studies demonstrating COVID-19’s effect on women’s ovarian reserve or fertility.
The authors suggest that recovered patients of COVID-19, especially those with infertility, should be further evaluated and followed up for their ovarian and testicular function.
This paper was presented in part at The American Society for Reproductive Medicine (ASRM) 2020 Virtual Scientific Congress & Expo, October 17-21, 2020 (as a Late Breaking News).
Related Blogs
Fertility Treatments
Pregnancy Tests
If the test is positive, you will be instructed to continue all medications (i.e. progesterone) and repeat the test in two days (or on Monday if it falls on a weekend).If 2nd blood test shows levels rising appropriately, you will be instructed to continue medications and schedule 1st OB ultrasound 7-10 days later. If levels are not rising appropriately, you will be instructed to return for further monitoring (lab draw and possible ultrasound as directed by your physician).
Infertility Resources & Support
Infertility Glossary
A glossary of popular medical terminology used in reproductive medicine.
Infertility Resources & Support
Advanced Age/Age Related Infertility
Many women are not aware of the extreme effect that age has on fertility. Women are born with all the eggs they will ever have in their lifetime and this pool of eggs declines continuously throughout a woman's life. The effects can be seen in a woman's early 30's and becomes a more common problem in women 35 and over.